+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report By Product (System, Consumables), By Modality, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 110 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 4418817
Description Jump to:
The global continuous renal replacement therapy market size is anticipated to reach USD 2, 603.8 million by 2030. The market is expected to expand at a CAGR of 8.6% from 2023 to 2030. The primary driving factors for market growth are increasing prevalence of congestive heart failure and acute renal failure. The COVID-19 is expected to have a positive impact on market due to increasing prevalence of acute kidney injury. According to a WHO, acute kidney injury, a potentially life-threatening condition in which the kidneys cease working and uremic and fluid toxins build up in the body, is one of the many COVID-19 side effects. As a result, as the COVID-19 outbreak expands, demand for CRRT will continue to climb.

Over the forecast period, technological advancements are expected to be a crucial driver in the growth of the market. For example, in August 2020, Baxter International Inc., a global leader in acute care, announced that Regiocit, the company's replacement solution containing citrate for extracorporeal circuit regional citrate anticoagulation, has acquired an Emergency Use Authorization (EUA) from the U.S Food and Drug Administration (FDA). Regiocit is exclusively approved for use as a replacement solution in adult patients receiving Continuous Renal Replacement Therapy (CRRT) and who require regional citrate anticoagulation during the COVID-19 pandemic, according to the EUA.

Continuous Renal Replacement Therapy Market Report Highlights

  • By product, the consumables segment held the largest revenue share of 60.6% in 2022. Although these products are low-priced, it is used repeatedly purchased; hence the market for consumables is the largest as compared to other segments
  • Based on the modality, the Continuous Veno-venous Hemofiltration (CVVH) segment held the largest revenue share of 31.6% in 2022. Fluid overload situations, which are common in acute kidney injury patients in critical care units, are expected to increase, boosting the CVVH market's growth
  • Asia Pacific was the fastest growing market for continuous renal replacement therapy with a growth rate of 9.8%. Various factors are responsible for the region growth such as technological advancement, growing healthcare infrastructure development as well as and presence of such a huge patient base in this region


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Modality
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Modality outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Continuous Renal Replacement Therapy Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Continuous Renal Replacement Therapy Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Continuous Renal Replacement Therapy Market: Product Estimates & Trend Analysis
4.1. Continuous Renal Replacement Therapy Market: Key Takeaways
4.2. Continuous Renal Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
4.3. System
4.3.1. System market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Consumables
4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Continuous Renal Replacement Therapy Market: Modality Class Estimates & Trend Analysis
5.1. Continuous Renal Replacement Therapy Market: Key Takeaways
5.2. Continuous Renal Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Slow Continuous Ultra-Filtration (SCUF)
5.3.1. Slow continuous ultra-filtration market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Continuous Venovenous Hemofiltration (CVVH)
5.4.1. Continuous venovenous hemofiltration (CVVH) market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Continuous Venovenous Hemodialysis (CVVHD)
5.5.1. Continuous venovenous hemodialysis (CVVHD) market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Continuous Venovenous Hemodiafiltration (CVVHDF)
5.6.1. Continuous venovenous hemodiafiltration (CVVHDF) market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Continuous Renal Replacement Therapy Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Continuous Renal Replacement Therapy Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. U.K.
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Participants
7.2. Market Participant Categorization
7.2.1. B. BRAUN MELSUNGEN AG
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. BAXTER INTERNATIONAL, INC.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. FRESENIUS MEDICAL CARE AG & CO. KGAA
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. ASAHI KASEI CORPORATION
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. NIPRO CORPORATION
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. TORAY MEDICAL CO., LTD.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. NXSTAGE MEDICAL, INC
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. MEDTRONIC PLC
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 3 North America continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 4 North America continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 7 Canada continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 8 Canada continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 9 Europe continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 10 Europe continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 11 Europe continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 12 Germany continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 13 Germany continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 14 UK continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 15 UK continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 16 France continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 17 France continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 18 Italy continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 19 Italy continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 20 Spain continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 21 Spain continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 22 Sweden continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 23 Sweden continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 24 Norway continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 25 Norway continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 26 Denmark continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 27 Denmark continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 28 Asia Pacific continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 29 Asia Pacific continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 30 Asia Pacific continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 31 Japan continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 32 Japan continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 33 China continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 34 China continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 35 India continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 36 India continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 37 Australia continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 38 Australia continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 39 Thailand continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 40 Thailand continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 41 South Korea continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 42 South Korea continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 43 Latin America continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 44 Latin America continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 45 Latin America continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 47 Brazil continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 48 Mexico continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 49 Mexico continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 50 Argentina continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 51 Argentina continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 56 South Africa continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 59 UAE continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 60 UAE continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 61 Kuwait continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 62 Kuwait continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Continuous renal replacement therapy: market outlook
Fig. 9 Continuous renal replacement therapy competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Continuous renal replacement therapy market driver impact
Fig. 15 Continuous renal replacement therapy market restraint impact
Fig. 16 Continuous renal replacement therapy market strategic initiatives analysis
Fig. 17 Continuous renal replacement therapy market: Product movement analysis
Fig. 18 Continuous renal replacement therapy market: Product outlook and key takeaways
Fig. 19 System market estimates and forecasts, 2018 - 2030
Fig. 20 Consumables market estimates and forecasts, 2018 - 2030
Fig. 21 Continuous renal replacement therapy market: Modality class outlook movement analysis
Fig. 22 Continuous renal replacement therapy market: Modality class outlook and key takeaways
Fig. 23 Slow continuous ultra-filtration market (SCUF) estimates and forecasts, 2018 - 2030
Fig. 24 Continuous venovenous hemofiltration (CVVH) market estimates and forecasts, 2018 - 2030
Fig. 25 Continuous venovenous hemodialysis (CVVHD) market estimates and forecasts, 2018 - 2030
Fig. 26 Continuous venovenous hemodiafiltration (CVVHDF) market estimates and forecasts, 2018 - 2030
Fig. 27 Continuous renal replacement therapy market: Regional movement analysis
Fig. 28 Continuous renal replacement therapy market: Regional outlook and key takeaways
Fig. 29 North America market estimates and forecasts, 2018 - 2030
Fig. 30 U.S. market estimates and forecasts, 2018 - 2030
Fig. 31 Canada market estimates and forecasts, 2018 - 2030
Fig. 32 Europe market estimates and forecasts, 2018 - 2030
Fig. 33 UK market estimates and forecasts, 2018 - 2030
Fig. 34 Germany market estimates and forecasts, 2018 - 2030
Fig. 35 France market estimates and forecasts, 2018 - 2030
Fig. 36 Italy market estimates and forecasts, 2018 - 2030
Fig. 37 Spain market estimates and forecasts, 2018 - 2030
Fig. 38 Sweden market estimates and forecasts, 2018 - 2030
Fig. 39 Norway market estimates and forecasts, 2018 - 2030
Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 42 Japan market estimates and forecasts, 2018 - 2030
Fig. 43 China market estimates and forecasts, 2018 - 2030
Fig. 44 India market estimates and forecasts, 2018 - 2030
Fig. 45 Australia market estimates and forecasts, 2018 - 2030
Fig. 46 Thailand market estimates and forecasts, 2018 - 2030
Fig. 47 South Korea market estimates and forecasts, 2018 - 2030
Fig. 48 Latin America market estimates and forecasts, 2018 - 2030
Fig. 49 Brazil market estimates and forecasts, 2018 - 2030
Fig. 50 Mexico market estimates and forecasts, 2018 - 2030
Fig. 51 Argentina market estimates and forecasts, 2018 - 2030
Fig. 52 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
Fig. 55 UAE market estimates and forecasts, 2018 - 2030
Fig. 56 Kuwait market estimates and forecasts, 2018 - 2030

Companies Mentioned

  • B. BRAUN MELSUNGEN AG
  • BAXTER INTERNATIONAL, INC.
  • FRESENIUS MEDICAL CARE AG & CO. KGAA
  • ASAHI KASEI CORPORATION
  • NIPRO CORPORATION
  • TORAY MEDICAL CO., LTD.
  • NXSTAGE MEDICAL, INC
  • MEDTRONIC PLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages110
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 1356.7 Million
Forecasted Market Value ( USD ) by 2030 $ 2603.8 Million
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Global Continuous Renal Replacement Therapy Market by Product, Modality, Age Group, Indication, End User - Forecast 2023-2030 - Product Image

Global Continuous Renal Replacement Therapy Market by Product, Modality, Age Group, Indication, End User - Forecast 2023-2030

  • Report
  • 187 Pages
  • Global
From
Continuous Renal Replacement Therapy (CRRT) - Global Strategic Business Report - Product Image

Continuous Renal Replacement Therapy (CRRT) - Global Strategic Business Report

  • Report
  • 216 Pages
  • Global
From
Global Continuous Renal Replacement Therapy (CRRT) Market Analysis & Forecast to 2024-2034 - Product Image

Global Continuous Renal Replacement Therapy (CRRT) Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Continuous Renal Replacement Therapy Market by Product (Hemofilter, Bloodline, Machines, Dialysates), Modality (SCUF, CVVH, CVVHD, CVVHDF), Age (Adult, Pediatric), Enduser (Hospitals, Ambulatory), and Region - Global Forecast to 2028 - Product Image

Continuous Renal Replacement Therapy Market by Product (Hemofilter, Bloodline, Machines, Dialysates), Modality (SCUF, CVVH, CVVHD, CVVHDF), Age (Adult, Pediatric), Enduser (Hospitals, Ambulatory), and Region - Global Forecast to 2028

  • Report
  • 226 Pages
  • Global
From
Global Continuous Renal Replacement Therapy Market: Focus on Modality, Product, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033 - Product Image

Global Continuous Renal Replacement Therapy Market: Focus on Modality, Product, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

  • Report
  • 149 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.